Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: Prevalence of E. coli ST131

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1727-1732

  Birgy, André ^a   Mariani Kurkdjian, Patricia ^a,b   Bidet, Philippe ^a,b   Doit, Catherine ^a,b   Genel, Nathalie ^c   Courroux, Céline ^a   Arlet, Guillaume ^c,d   Bingen, Edouard ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LATAMOXEF; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TICARCILLIN; TIMENTIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; BLA CTX M 1 GENE; BLA CTX M 14 GENE; BLA CTX M 15 GENE; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; FRANCE; GENETIC VARIABILITY; HUMAN; MOLECULAR EPIDEMIOLOGY; MOTHER FETUS RELATIONSHIP; NEWBORN; NONHUMAN; PATHOGENICITY ISLAND; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; VAGINA SMEAR; VULNERABLE POPULATION;

ADULT; BETA-LACTAMASES; BLOOD; CEREBROSPINAL FLUID; CLUSTER ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FRANCE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT, NEWBORN; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHYLOGENY; PREVALENCE; VAGINA; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 84878512574     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03255-12     Document Type: Article

References (41)

1. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
2. Cantón R, Coque TM. 2006. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9:466-475.
3. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. (Pubitemid 351249250)
4. Pitout JD, Nordmann P, Laupland KB, Poirel L. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59. (Pubitemid 41418336)
5. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
6. Boyer-Mariotte S, Duboc P, Bonacorsi S, Lemeland JF, Bingen E, Pinquier D. 2008. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J. Antimicrob. Chemother. 62:1472-1474.
7. Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentré F, Wolff M, Denamur E, Branger C. 2011. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin. Microbiol. Infect. 17:557-565.
8. Shakil S, Akram M, Ali SM, Khan AU. 2010. Acquisition of extended-spectrum beta-lactamase producing Escherichia coli strains in male and female infants admitted to a neonatal intensive care unit: molecular epidemiology and analysis of risk factors. J. Med. Microbiol. 59:948-954.
9. Blaschke AJ, Korgenski EK, Daly JA, LaFleur B, Pavia AT, Byington CL. 2009. Extended-spectrum beta-lactamase-producing pathogens in a children's hospital: a 5-year experience. Am. J. Infect. Control 37:435-441.
10. Bingen E, Bidet P, Birgy A, Sobral E, Mariani P, Cohen R. 2012. In vitro interaction between cefixime and amoxicillin-clavulanate against extended-spectrum-beta-lactamase-producing Escherichia coli causing urinary tract infection. J. Clin. Microbiol. 50:2540-2541.
11. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Drieux L, Brossier F, Sougakoff W, Jarlier V. 2008. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. Clin. Microbiol. Infect. 14(Suppl 1):90-103. (Pubitemid 350269190)
13. Dallenne C, Da Costa A, Decre D, Favier C, Arlet G. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. 65:490-495.
14. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G. 2004. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48:1249-1255. (Pubitemid 38405479)
15. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
16. Bingen-Bidois M, Clermont O, Bonacorsi S, Terki M, Brahimi N, Loukil C, Barraud D, Bingen E. 2002. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect. Immun. 70:3216-3226. (Pubitemid 34564186)
17. Bidet P, Mahjoub-Messai F, Blanco J, Blanco J, Dehem M, Aujard Y, Bingen E, Bonacorsi S. 2007. Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis. J. Infect. Dis. 196:297-303. (Pubitemid 47047470)
18. Bonacorsi SPP, Clermont O, Tinsley C, Le Gall I, Beaudoin JC, Elion J, Nassif X, Bingen E. 2000. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect. Immun. 68:2096-2101. (Pubitemid 30164841)
19. Clermont O, Dhanji H, Upton M, Gibreel T, Fox A, Boyd D, Mulvey MR, Nordmann P, Ruppé E, Sarthou JL, Frank T, Vimont S, Arlet G, Branger C, Woodford N, Denamur E. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
20. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon JM, Garry L, Clermont O, Denamur E, Arlet G, Vandewalle A. 2012. The CTX-M-15-producing Escherichia coli clone O25b:H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 7:e46547. doi:10.1371/journal.pone.0046547.
21. Pitout JD, Campbell L, Church DL, Wang PW, Guttman DS, Gregson DB. 2009. Using a commercial DiversiLab semiautomated repetitive sequence-based PCR typing technique for identification of Escherichia coli clone ST131 producing CTX-M-15. J. Clin. Microbiol. 47:1212-1215.
22. Lau SH, Cheesborough J, Kaufmann ME, Woodford N, Dodgson AR, Dodgson KJ, Bolton EJ, Fox AJ, Upton M. 2009. Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system. Clin. Microbiol. Infect. 16:232-237.
23. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
24. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, Coque TM. 2008. Prevalence and spread of extended-spectrum beta-lactamase- producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl 1):144-153. (Pubitemid 350269194)
25. Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M, Thollot F, Bingen E. 2012. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children. BMC Infect. Dis. 12:315. doi:10.1186/1471-2334-12-315.
26. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. 2004. Dramatic increase in prevalence of fecal carriage of extended- spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775. (Pubitemid 39362401)
27. Hawkey PM. 2008. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin. Microbiol. Infect. 14(Suppl 1):159-165. (Pubitemid 350269196)
28. Wu TL, Chia JH, Su LH, Kuo AJ, Chu C, Chiu CH. 2003. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J. Clin. Microbiol. 41:4836-4838. (Pubitemid 37259810)
29. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, Paradisi F, Kronvall G, Rossolini GM. 2004. Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob. Agents Chemother. 48:4556-4561. (Pubitemid 39577653)
30. Chandramohan L, Revell PA. 2012. Prevalence and molecular characterization of extended-spectrum-β-lactamase-producing Enterobacteriaceae in a pediatric patient population. Antimicrob. Agents Chemother. 56:4765-4770.
31. Brisse S, Diancourt L, Laouenan C, Vigan M, Caro V, Arlet G, Drieux L, Leflon-Guibout V, Mentré F, Jarlier V, Nicolas-Chanoine MH, Coli β Study Group. 2012. Phylogenetic distribution of CTX-M- and non-extended- spectrum-β-lactamase-producing Escherichia coli isolates: group B2 isolates, except clone ST131, rarely produce CTX-M enzymes. J. Clin. Microbiol. 50:2974-2981.
32. Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, Gouriou S, Picard B, Denamur E. 2005. Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg. Infect. Dis. 11:54-61. (Pubitemid 40093353)
33. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
34. Oteo J, Cercenado E, Fernández-Romero S, Saéz D, Padilla B, Zamora E, Cuevas O, Bautista V, Campos J. 2012. Extended-spectrum-β- lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain. Antimicrob. Agents Chemother. 56:54-58.
35. CTX-M-15 among extended-spectrum-beta-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob. Agents Chemother. 56:2364-2370.
36. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028. (Pubitemid 351524443)
37. Van der Bij AK, Peirano G, Pitondo-Silva A, Pitout JD. 2012. The presence of genes encoding for different virulence factors in clonally related Escherichia coli that produce CTX-Ms. Diagn. Microbiol. Infect. Dis. 72:297-302.
38. Lavigne JP, Vergunst AC, Goret L, Sotto A, Combescure C, Blanco J, O'Callaghan D, Nicolas-Chanoine MH. 2012. Virulence potential and genomic mapping of the worldwide clone Escherichia coli ST131. PLoS One 7:e34294. doi:10.1371/journal.pone.0034294.
39. Coelho A, Mora A, Mamani R, López C, González-López JJ, Larrosa MN, Quintero-Zarate JN, Dahbi G, Herrera A, Blanco JE, Blanco M, Alonso MP, Prats G, Blanco J. 2011. Spread of Escherichia coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12 with high virulence gene content in Barcelona (Spain). J. Antimicrob. Chemother. 66:517-526.
40. Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
41. Rodriguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. 2008. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J. Antimicrob. Chemother. 62:1142-1149.